CEO Interview: Roche Pharma Head Daniel O'Day On R&D Strategy

In an interview with Scrip, Roche Pharma CEO Daniel O'Day emphasized the importance that personalized healthcare will have in transforming R&D and how patients are treated.

Roche
Roche's Late Stage Pipeline Is At A Record High, O'Day Says • Source: Shutterstock

More from R&D

More from Scrip